| 000 | 01663 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514051140.0 | ||
| 264 | 0 | _c20021127 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a0361-8609 | ||
| 024 | 7 |
_a10.1002/ajh.10215 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Deventer, Hendrik W | |
| 245 | 0 | 0 |
_aClinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemia. _h[electronic resource] |
| 260 |
_bAmerican journal of hematology _cNov 2002 |
||
| 300 |
_a184-90 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 | _aCytogenetic Analysis |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Accelerated Phase _xdrug therapy |
| 650 | 0 | 4 |
_aMegakaryocytes _xpathology |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aHall, Melissa D | |
| 700 | 1 | _aOrlowski, Robert Z | |
| 700 | 1 | _aMitchell, Beverly S | |
| 700 | 1 | _aBerkowitz, Lee R | |
| 700 | 1 | _aHogan, Cathe | |
| 700 | 1 | _aDunphy, Cherie H | |
| 700 | 1 | _aKoehler, Julie | |
| 700 | 1 | _aShea, Thomas C | |
| 773 | 0 |
_tAmerican journal of hematology _gvol. 71 _gno. 3 _gp. 184-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.10215 _zAvailable from publisher's website |
| 999 |
_c12218710 _d12218710 |
||